 |
|
If you need to get a quote for any product, or have any questions, please fill in the
following contact form, we will contact you within 24 hours. If your have an account with us, click here to login to retrieve your information.
| Your Contact Information (Required *) |
| First Name* |
|
| Last Name* |
|
| E-Mail* |
|
| Company Name* |
|
| Address |
|
| City |
|
| State |
|
| Zip |
|
| Country |
|
| Phone |
|
| Fax |
|
| Web Site |
|
| |
| Products Interested (Browsing products) |
|
| Product ID |
CAS Number |
Product Name |
Quantity |
| A1-0174 |
184954-75-4 |
1-N-Boc-1,2-cis-Cyclohexyldiamine |
|
| A1-3121 |
768-66-1 |
2,2,6,6-tetramethylpiperidine |
|
| A1-9086 |
58481-04-2 |
2-Chloro-isonicotinic acid hydrazide |
|
| A1-9315 |
34368-52-0 |
(S)-3-Hydroxy-2-pyrrolidinone |
|
| BTC-001701 |
4593-38-8 |
5-Methyl-1-indanone |
|
| BTC-003292 |
51173-04-7 |
2-Methoxy-5-fluoropyridine |
|
| BTC-010774 |
163457-23-6 |
Pyrrolidine, 3,3-difluoro-, hydrochloride |
|
| JR6-L1557 |
1044789-45-8 |
Borate(1-), [2-[(hydroxy-O)methyl]-2-methyl-1,3-propanediolato(3-)-O1,O3](6-methyl-2-pyridinyl)-, lithium (1:1), (T-4)- |
|
| JR6-L1912 |
1188412-37-4 |
Benzeneethanol, a,2-dimethyl-5-(trifluoromethyl)-, (aR)- |
|
| JR6-L2038 |
52462-29-0 |
Di-mu-chlorobis(p-cymene)chlororuthenium(II) |
|
| JR6-L2270 |
1185530-03-3 |
Glycinamide, 3-methyl-L-valyl- |
|
| JR6-L2310 |
198422-14-9 |
Butanamide, 2-amino-3,3-dimethyl-N-[2-(4-morpholinyl)ethyl]-, (2S)- |
|
| JR6-L2312 |
1097968-27-8 |
Benzoic acid, 4-[[(2S)-2-amino-3,3-dimethyl-1-oxobutyl]amino]-, methyl ester |
|
| JR6-L2329 |
924265-90-7 |
2-Thiazolidinethione, 4-(2,4,6-trimethylphenyl)-, (4S)- |
|
| JR6-L2351 |
122889-25-2 |
2-Thiazolidinethione, 4-(1-methylethyl)-3-(1-oxodecyl)-, (S)- (9CI) |
|
| JR6-L2573 |
342603-65-0 |
Carbamic acid, N-[2-(methoxymethylamino)-1-methyl-2-oxoethyl]-, 1,1-dimethylethyl ester |
|
| JR6-L2671 |
141303-34-6 |
Oxirane, 2-(3,4-dichlorophenyl)-, (2R)- |
|
| JR6-L2735 |
70160-51-9 |
2H-1-Benzopyran-3-carboxylic acid, 6-hydroxy-2-oxo-, ethyl ester |
|
| JR6-L2789 |
129880-84-8 |
5-Thiazolecarboxaldehyde, 4-chloro-2-(4-morpholinyl)- |
|
| JR6-L2793 |
199851-22-4 |
5-Thiazolecarboxaldehyde, 4-chloro-2-[(1,1-dimethylethyl)amino]- |
|
| JR6-L3066 |
92933-15-8 |
1,2-Benzisothiazole, 3-[1-(cyclopropylmethyl)-4-piperidinyl]- |
|
| JR6-L3186 |
1210041-74-9 |
[1,1'-Binaphthalen]-2-ol, 2'-amino-3,3'-dimethyl-, (1S)- |
|
| JR6-L3326 |
208338-46-9 |
[1,1'-Binaphthalene]-2,2'-diol, 6,6'-diethyl-, (1R)- |
|
| JR6-L3499 |
141036-66-0 |
Oxirane, 2-(2-phenylethyl)-, (2R)- |
|
| JR6-L3950 |
1252665-06-7 |
1-Butanone, 4-chloro-1-(2,3-difluorophenyl)- |
|
| JR6-L3985 |
133437-57-7 |
Methanone, (2,3-difluorophenyl)(2-methyl-1H-indol-3-yl)- |
|
| JR6-L4273 |
1117761-00-8 |
Phenol, 4,4'-[[1-(2,4-dinitrophenyl)-1H-pyrazole-3,5-diyl]di-(1E)-2,1-ethenediyl]bis[2-methoxy- |
|
| JR6-L4324 |
1350752-33-8 |
Hexadecanoic acid, 16-[[3-[[[(2-cyano-6-benzothiazolyl)oxy]carbonyl]oxy]propyl]dithio]- |
|
| JR6-L4442 |
1192609-03-2 |
Benzonitrile, 2-chloro-4-[(3R)-3-hydroxy-1-pyrrolidinyl]- |
|
| JR6-L4444 |
1204427-60-0 |
Methanone, (4-hydroxyphenyl)[(3S)-3-hydroxy-1-pyrrolidinyl]- |
|
| JR6-L4456 |
101469-92-5 |
1-Pyrrolidinecarboxylic acid, 3-hydroxy-, 1,1-dimethylethyl ester, (3S)- |
|
| JR6-L4510 |
1161730-33-1 |
3-Pyrrolidinol, 1-(6-chloro-2-benzothiazolyl)-, (3S)- |
|
| JR6-L4520 |
122536-69-0 |
1-Pyrrolidinecarboxylic acid, 3-[(methylsulfonyl)oxy]-, phenylmethyl ester, (3S)- |
|
| JR6-L4655 |
1051384-16-7 |
Spiro[2H-1-benzopyran-2,4'-piperidine]-1'-carboxylic acid, 3,4-dihydro-3,3-dimethyl-4-oxo-, 1,1-dimethylethyl ester |
|
| JR6-L4723 |
1207163-58-3 |
Spiro[2H-1-benzopyran-2,4'-piperidine]-1'-carboxylic acid, 5,8-difluoro-3,4-dihydro-4-oxo-, 1,1-dimethylethyl ester |
|
| JR6-L4725 |
1134815-23-8 |
Spiro[2H-1-benzopyran-2,4'-piperidine]-1'-carboxylic acid, 5,8-dichloro-3,4-dihydro-4-oxo-, 1,1-dimethylethyl ester |
|
| JR6-L4733 |
1192540-04-7 |
Spiro[2H-1-benzopyran-2,4'-piperidine]-1'-carboxylic acid, 7-bromo-3,4-dihydro-6-methoxy-4-oxo-, 1,1-dimethylethyl ester |
|
| JR6-L4739 |
1051383-41-5 |
Spiro[2H-1-benzopyran-2,4'-piperidine]-1'-carboxylic acid, 3,4-dihydro-4-oxo-6-(phenylmethoxy)-, 1,1-dimethylethyl ester |
|
| JR6-L4857 |
93315-12-9 |
Cyclobutanecarbonitrile, 1-[1,1'-biphenyl]-4-yl- |
|
| JR6-L4908 |
64399-27-5 |
Cyclopropanecarbonitrile, 1-(4-chlorophenyl)- |
|
| JR6-L5075 |
622799-86-4 |
1H-Indole-3-methanamine, N-(3,4-dimethylphenyl)-a-(2-methoxyphenyl)-2-methyl- |
|
| JR6-L5519 |
439607-93-9 |
Naphth[1,2-d]oxazole, 2-chloro- |
|
| JR6-L6176 |
301681-58-3 |
Benzamide, N-[4-[[(3,4-dimethyl-5-isoxazolyl)amino]sulfonyl]phenyl]-3,4-dimethoxy- |
|
| JR6-L6184 |
1204290-35-6 |
Benzenesulfonamide, 4-[(1,4-dihydro-3-methyl-1,4-dioxo-2-naphthalenyl)amino]-N-(3,4-dimethyl-5-isoxazolyl)- |
|
| JR6-L6425 |
337536-20-6 |
Boronic acid, [4-[1-hydroxy-2-methyl-1-[1-(triphenylmethyl)-1H-imidazol-4-yl]propyl]phenyl]- (9CI) |
|
| JR6-L6458 |
596120-49-9 |
Benzoic acid, 2-nitro-4-[3-(trifluoromethyl)-3H-diazirin-3-yl]- |
|
| JR6-L6753 |
321-07-3 |
3H-Pyrazol-3-one, 2,4-dihydro-2-phenyl-5-(trifluoromethyl)- |
|
| JR6-L7446 |
1353530-03-6 |
1-Piperidinecarboxylic acid, 4-[5-[(2R)-2,3-dihydroxypropyl]-3-fluoro-2-pyridinyl]-4-fluoro-, 1,1-dimethylethyl ester |
|
| JR6-L7506 |
1335390-86-7 |
3-Pyridineethanamine, 5-methoxy-a-methyl-, (aS)- |
|
| JR6-L7661 |
404875-99-6 |
2-Pyridinemethanamine, 3-chloro-a-methyl-5-(trifluoromethyl)-, (aR)- |
|
| JR6-L7954 |
1344599-17-2 |
2H-Indol-2-one, 3-amino-4-bromo-1,3-dihydro-3-methyl-, (3R)- |
|
| JR8-N0044 |
14197-60-5 |
Ginsenoside Rg3 |
|
| JR8-N0117 |
633-65-8 |
Berberine Hydrochloride |
|
| JR8-N0163 |
13476-25-0 |
Linderane |
|
| JR8-N0167 |
13463-28-0 |
Eriocitrin |
|
| JR8-N0174 |
37921-38-3 |
Cimifugin |
|
| JR8-N0335 |
118-34-3 |
Syringin |
|
| JR8-N0465 |
1818-71-9 |
Crotonoside |
|
| JR8-N0466 |
83-46-5 |
ß-Sitosterol |
|
| JR8-N0518 |
7084-24-4 |
Cyanidin-3-O-glucoside chloride |
|
| JR8-N0521 |
2009-24-7 |
Xanthotol |
|
| JR8-N0531 |
53452-16-7 |
Vaccarin |
|
| JR8-N0710 |
6681-15-8 |
Jatrorrhizine hydrochloride |
|
| JR8-N1242 |
125265-68-1 |
Asiaticoside B |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Comments |
| |
|
 |
|
|
|
|
|
|